These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 10401972

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
    Moore LL, Valuck R, McDougall C, Fink W.
    Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
    [Abstract] [Full Text] [Related]

  • 4. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Progestin-only contraceptives: effects on weight.
    Lopez LM, Ramesh S, Chen M, Edelman A, Otterness C, Trussell J, Helmerhorst FM.
    Cochrane Database Syst Rev; 2016 Aug 28; 2016(8):CD008815. PubMed ID: 27567593
    [Abstract] [Full Text] [Related]

  • 8. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M, Liblanc M.
    J Adolesc Health; 1998 Aug 28; 23(2):81-8. PubMed ID: 9714170
    [Abstract] [Full Text] [Related]

  • 9. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
    Virutamasen P, Wangsuphachart S, Reinprayoon D, Kriengsinyot R, Leepipatpaiboon S, Gua C.
    Asia Oceania J Obstet Gynaecol; 1994 Sep 28; 20(3):269-74. PubMed ID: 7811192
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR.
    BMJ; 1991 Jul 06; 303(6793):13-6. PubMed ID: 1830502
    [Abstract] [Full Text] [Related]

  • 12. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
    Pardthaisong T, Gray RH, McDaniel EB.
    Lancet; 1980 Mar 08; 1(8167):509-12. PubMed ID: 6102234
    [Abstract] [Full Text] [Related]

  • 13. Adolescent satisfaction with postpartum contraception and body weight concerns.
    Hellerstedt WL, Story M.
    J Adolesc Health; 1998 Jun 08; 22(6):446-52. PubMed ID: 9627814
    [Abstract] [Full Text] [Related]

  • 14. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z, Biro FM, Kollar LM.
    J Adolesc Health; 1995 May 08; 16(5):379-84. PubMed ID: 7662688
    [Abstract] [Full Text] [Related]

  • 15. Progestin-only contraceptives: effects on weight.
    Lopez LM, Edelman A, Chen M, Otterness C, Trussell J, Helmerhorst FM.
    Cochrane Database Syst Rev; 2013 Jul 02; 7(7):CD008815. PubMed ID: 23821307
    [Abstract] [Full Text] [Related]

  • 16. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS, Dalberth BT, Cañamar R, Betz M.
    Contraception; 1997 Nov 02; 56(5):305-12. PubMed ID: 9437559
    [Abstract] [Full Text] [Related]

  • 17. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
    Lei ZW, Wu SC, Garceau RJ, Jiang S, Yang QZ, Wang WL, Vander Meulen TC.
    Contraception; 1996 Jun 02; 53(6):357-61. PubMed ID: 8773423
    [Abstract] [Full Text] [Related]

  • 18. Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate.
    Mangan SA, Larsen PG, Hudson S.
    J Pediatr Adolesc Gynecol; 2002 Apr 02; 15(2):79-82. PubMed ID: 12057528
    [Abstract] [Full Text] [Related]

  • 19. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B, Ellis S, Murby B, Randall S, Kirkman R.
    Br J Obstet Gynaecol; 1998 Jul 02; 105(7):790-4. PubMed ID: 9692421
    [Abstract] [Full Text] [Related]

  • 20. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception.
    Clark MK, Dillon JS, Sowers M, Nichols S.
    Int J Obes (Lond); 2005 Oct 02; 29(10):1252-8. PubMed ID: 15997247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.